Filing Flows › ANI Pharmaceuticals (ANIP) › Q2 2026
ANI Pharmaceuticals (ANIP) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 7, 2026
ANI Pharmaceuticals (ANIP) reported revenue of $266M for the second quarter 2026 (Q2 2026), +26% from a year earlier and +12% from the quarter before. Operating margin was 15.2%, net earnings $24.7M (9.3% of revenue).
ANI Pharmaceuticals, Q2 2026: revenue $266M (+26% year over year), operating margin 15.2%, net earnings $24.7M, operating cash flow $56.7M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $266M | +12% | +26% |
| Operating profit | $40.5M | +4% | +191% |
| Net earnings | $24.7M | -16% | +189% |
| Operating cash flow | $56.7M | -3% | -25% |
| Free cash flow | $53.6M | +3% | -25% |
What changed
Revenue was $266.0M in Q2 2026, up 26% year over year and up 12% from the previous quarter. Cortrophin Gel was the largest line at 44% of revenue. Cortrophin Gel added $35.5M year over year (up 43%), 65% of the total change. Other generic revenues declined 59%.
Operating profit was $40.5M, a 15.2% margin (up 8.6 points year over year). Of the extra revenue versus Q2 2025, 49% reached operating profit, above the 7% margin then. Total costs grew 14% against revenue growth of 26%. The fastest-growing cost line was Cost of revenue (+34%). Net earnings were $24.7M, up 189% year over year. The effective tax rate was 33.4%.
Operating cash flow was $56.7M (down 25% year over year), 229% of net earnings. Non-cash charges added back $19.6M of depreciation and amortization and $11.4M of share-based compensation. Capital expenditures of $3.1M left free cash flow of $53.6M.
Questions
What was ANI Pharmaceuticals' revenue in the second quarter 2026?
ANI Pharmaceuticals (ANIP) reported revenue of $266M for the second quarter 2026 (Q2 2026), +26% from a year earlier and +12% from the quarter before.
Was ANI Pharmaceuticals profitable in the second quarter 2026?
Operating profit was $40.5M (15.2% of revenue) and net earnings $24.7M.